Methods for modulating activities in plants

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S330000

Reexamination Certificate

active

07851448

ABSTRACT:
The invention relates to methods for modulating, treating and preventing conditions in seeds and plants. The methods include the use of a composition comprising SEQ ID NO: 1, optionally with one or two conservative substitutions or a nucleic acid of the above.

REFERENCES:
patent: 5189064 (1993-02-01), Blum et al.
patent: 5328836 (1994-07-01), Shima et al.
patent: 5492894 (1996-02-01), Bascom et al.
patent: 5506202 (1996-04-01), Vertesy et al.
patent: 5705621 (1998-01-01), Ravikumar
patent: 5760044 (1998-06-01), Archer
patent: 5854226 (1998-12-01), Penkler et al.
patent: 6419931 (2002-07-01), Vitiello et al.
patent: 6689363 (2004-02-01), Sette et al.
patent: 6794144 (2004-09-01), Saksela et al.
patent: 6849714 (2005-02-01), Bridon et al.
patent: 7244599 (2007-07-01), Tanner et al.
patent: 7557088 (2009-07-01), Skubatch
patent: 2004/0254343 (2004-12-01), Miyakaki et al.
patent: 2006/0154863 (2006-07-01), Skubatch
patent: 2007/0185029 (2007-08-01), Skubatch
patent: 2007/0259818 (2007-11-01), Skubatch
patent: 2009/0069237 (2009-03-01), Skubatch
patent: 2009/0170784 (2009-07-01), Skubatch
patent: 2010/0137227 (2010-06-01), Skubatch
patent: 4433564 (1996-04-01), None
patent: 0514268 (1992-11-01), None
patent: 0966975 (1999-12-01), None
patent: 0966975 (2002-04-01), None
patent: 0966975 (2005-09-01), None
patent: 6-107683 (1994-04-01), None
patent: WO 97/44447 (1997-11-01), None
patent: WO 97/44447 (1998-03-01), None
patent: WO 00/54805 (2000-09-01), None
patent: WO 00/69900 (2000-11-01), None
patent: WO 00/69900 (2001-02-01), None
patent: WO 02/19986 (2002-03-01), None
patent: WO 00/69900 (2002-07-01), None
patent: WO 02/060432 (2002-08-01), None
patent: WO 02/066625 (2002-08-01), None
patent: WO 03/006654 (2003-01-01), None
patent: WO 03/006654 (2003-10-01), None
patent: WO 2004/054614 (2004-07-01), None
patent: WO 2004/058804 (2004-07-01), None
patent: WO 2004/098644 (2004-11-01), None
patent: WO 2004/099135 (2004-11-01), None
patent: WO 2004/101797 (2004-11-01), None
patent: WO 2004/099135 (2005-02-01), None
patent: WO 2006/000034 (2006-01-01), None
patent: WO 2006/006172 (2006-01-01), None
patent: WO 2006/006172 (2006-05-01), None
patent: WO 2006/045313 (2006-05-01), None
patent: WO 2006/045314 (2006-05-01), None
patent: WO 2006/045319 (2006-05-01), None
patent: WO 2006/068768 (2006-06-01), None
patent: WO 2006/045313 (2006-08-01), None
patent: WO 2006/045319 (2006-09-01), None
patent: WO 2006/045314 (2007-04-01), None
patent: WO 2006/068768 (2008-01-01), None
A.P. Keninath et al. Crop Protection (2000) 19, pp. 501-509.
D. Syamsuwida and J.N. Owens. Tree Physiol. (1997) 17, pp. 211-219.
J. Larkindale and M.R. Knight. Plant Physiol. (2002) 128, pp. 682-685.
Hruby, et al. Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain. 2003; 73:699-704.
Hruby, et al. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors. Biopolymers. 1999; 51(6):391-410.
Bertoletti, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol. 1993; 67(4):2376-80.
Hawks. et al. Opioid Peptides. Drug Abuse Research Monograph. # 70, 1986.
McPherson. A comparison of salts for the crystallization of macromolecules. Protein Sci. 2001; 10(2):418-22.
Pikal, et al. The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form. Pharm Res. 1997; 14(10):1379-87.
Shenoy, et al. Stability of crystalline proteins. Biotechnol Bioeng. 2001; 73(5):358-69.
Chen, et al. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature. 1998; 394:793-7.
Dinkova-Kostova, A., et al. (+)-Pinoresinol/(+)-Lariciresinol Reductase from Forsythia Intermedia. J. Biol. Chem. 1996; 271(46):29473-82.
Fujita, et al. Recombinant pinoresinol-lariciresinol reductases from western red cedar (Thuja plicata) catalyze opposite enantiospecific conversions. J. Biol. Chem. 1999; 274(2):618-27.
Gang, D. et al. Evolution of Plant Defense Mechanism. J. Biol. Chem. 1999; 274(11):7516-7527.
Horikawa, et al. Isolation and structural organization of the human preproenkephalin B gene. Nature. 1983; 306:611-4.
Latvala-Kilby, et al. The complete nucleotide sequence of RNA2 of blackcurrant reversion nepovirus. Virus Research. 1999; 65:87-92.
Lers, et al. The expression of a grapefruit gene encoding an isoflavone reductase-like protein is induced in response to UV irradiation. Plant Mol. Biol. 1998; 36:847-56.
Messer, W. S. Vasopressin and Oxytocin. This page was last updated on Monday, Apr. 3, 2000. Available at http://www.neurosci.pharm.utoledo.edu/MBC3320/vasopressin.htm. Accessed Dec. 19, 2006.
NCBI Database Accession No. AAC50454, Feb. 28, 2006.
NCBI Database Accession No. AAD09329, Feb. 28, 2006.
NCBI Database Accession No. NP—001017915, Feb. 28, 2006.
NCBI Database Accession No. NP—005532, Feb. 28, 2006.
Shorter, et al. GRASP55, a second mammalian GRASP protein involved in the stacking of Golgi cisternae in a cell-free system. EMBO J. 1999; 18(18):4949-60.
Gimbel, et al. The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain. Anesth Analg. Nov. 2004;99(5):1472-7.
International search report dated Oct. 29, 2008 for PCT Application No. US2008/064171.
International search report dated Nov. 13, 2007 for PCT Application No. US2005/42682.
International search report dated Feb. 10, 2009 for PCT Application No. US2008/70534.
International search report dated Sep. 29, 2008 for PCT Application No. US2007/65404.
Kiyatkin, et al. Brain and body hyperthermia associated with heroin self-administration in rats. J Neurosci. Feb. 1, 2002;22(3):1072-80.
Lufty, et al. Orphanin FQ
ociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl). Nov. 2002;164(2):168-76.
Moore, et al. The efficacy of locally applied morphine in post-operative pain after bilateral third molar surgery. Br J Clin Pharmacol. Mar. 1994;37(3):227-30.
Reimer-Kent, J. From theory to practice: preventing pain after cardiac surgery. Am J Crit Care. Mar. 2003;12(2):136-43.
Unlugenc, et al. Pre-emptive analgesic efficacy of tramadol compared with morphine after major abdominal surgery. Br J Anaesth. Aug. 2003;91(2):209-13.
Weiss, et al. A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules. Chem Biol. Jun. 1995;2(6):401-7.
Salzet, M. Neuroimmunology of opioids from invertebrates to human. Neuro Endocrinol Lett. Dec. 2001;22(6):467-74.
Catania, et al. Peptide modulation of fever and inflammation within the brain. Ann N Y Acad Sci. Sep. 29, 1998;856:62-8.
Emel'Ianova, et al. Effect of dermorphin analogs on thermoregulation of rats under various thermal conditions. Biology Bulletin. 2002; 29(3):284-289. (Translated from Izv Akad Nauk Ser Biol. May-Jun. 2002;(3):348-54.).
European search report dated Jun. 7, 2010 for Application No. 5852156.8.
Kalliomaki, et al. Prolactin-releasing peptide affects pain, allodynia and autonomic reflexes through medullary mechanisms. Neuropharmacology. Mar. 2004;46(3):412-24.
Le Guen, et al. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone. Pain. Jul. 2003;104(1-2):139-48.
Tatro, et al. The central melanocortin system and fever. Ann N Y Acad Sci. Jun. 2003;994:246-57.
Wollemann, et al. Non-opioid actions of opioid peptides. Life Sci. Jun. 4, 2004;75(3):257-70.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for modulating activities in plants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for modulating activities in plants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating activities in plants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4227496

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.